Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Medidata Solutions Inc    MDSO

MEDIDATA SOLUTIONS INC (MDSO)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Medidata Solutions Inc : Medidata Solutions Announces Two-for-One Stock Split

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/11/2013 | 12:31pm CET

Medidata Solutions (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that its Board of Directors approved a two-for-one (2:1) split of the Company's common stock at a regularly scheduled board meeting on November 7, 2013. The stock split will be structured in the form of a stock dividend.

The record date for the stock split is December 2, 2013. Shareholders of record as of such date will receive one new share of common stock for each share that they own. The distribution of the new shares will be made on December 16, 2013, and trading on a split-adjusted basis is expected to begin on or about December 17, 2013.

Medidata had approximately 26.8 million shares of common stock outstanding as of November 7, 2013. The stock split will increase the common shares outstanding to approximately 53.6 million.

About Medidata Solutions

Medidata Solutions is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud TM brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. We are committed to advancing the competitive and scientific goals of our global customers, which include over 90% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations.

Investors:
Medidata Solutions
Hulus Alpay, 212-419-1025
[email protected]
or
Media:
Medidata Solutions
Gail Janowitz, 212-918-1792
[email protected]


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MEDIDATA SOLUTIONS INC
02:43p MEDIDATA : New Quartesian Agreement with Medidata Expands Sponsor Access to the ..
12/06 MEDIDATA : SCA Wins Scrip Award for Best Technological Development in Clinical T..
12/05 MEDIDATA : Expands Partnership with CytomX Therapeutics to Centralize Management..
12/05 MEDIDATA : Industry Survey Reveals Top 14 Technologies Necessary for a Unified e..
11/28 MEDIDATA : Presenting at the 2017 Partnerships in Clinical Trials Europe Confere..
11/21 MEDIDATA : NYU Langone's 2017 Musculoskeletal Ball Raises More Than $1.3 Million..
11/21 MEDIDATA : to Present at Piper Jaffray Healthcare Conference
11/20 MEDIDATA : Global Medical Devices Company, MEL MEDICAL Enterprises, Modernizes C..
11/16 MEDIDATA : NYU Langone's 2017 Musculoskeletal Ball Raises More Than $1.3 Million..
11/10 MEDIDATA : Honors 2017 Architects of Hope Award Winners at Medidata : NEXT Globa..
More news
News from SeekingAlpha
12/08 Deutsche Bank initiates Medidata
12/08 Premarket analyst action - healthcare
12/01 Premarket analyst action - healthcare
11/13 Dougherty & Company upgrades Medidata on reduced risks
11/10 Medidata Solutions (MDSO) Investor Presentation - Slideshow
Financials ($)
Sales 2017 545 M
EBIT 2017 122 M
Net income 2017 38,6 M
Finance 2017 74,1 M
Yield 2017 -
P/E ratio 2017 103,11
P/E ratio 2018 87,77
EV / Sales 2017 6,98x
EV / Sales 2018 5,85x
Capitalization 3 881 M
Chart MEDIDATA SOLUTIONS INC
Duration : Period :
Medidata Solutions Inc Technical Analysis Chart | MDSO | US58471A1051 | 4-Traders
Technical analysis trends MEDIDATA SOLUTIONS INC
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 83,4 $
Spread / Average Target 26%
EPS Revisions
Managers
NameTitle
Tarek A. Sherif Chairman & Chief Executive Officer
Glen Michael de Vries President & Director
Michael L. Capone Chief Operating Officer
Rouven Bergmann Chief Financial & Accounting Officer
Julie Iskow Chief Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
MEDIDATA SOLUTIONS INC31.81%3 885
INTERNATIONAL BUSINESS MACHINES CORPORATION-6.74%143 877
ACCENTURE26.87%96 605
TATA CONSULTANCY SERVICES LIMITED9.86%79 005
AUTOMATIC DATA PROCESSING12.88%52 252
VMWARE, INC.51.87%49 519